OncoSec Medical to Present at the 2013 BIO International Convention on April 24

SAN DIEGO – April 17, 2013 — OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present a company overview at the 2013 BIO International Convention. Mr. Dhillon’s presentation will take place on Wednesday, April 24, 2013 at 9:00 a.m. CT at the McCormick Place convention center in Chicago, IL.

About Bio International Convention 2013

Bio International Convention is the global event for the biotechnology industry attracting over 16,000 decision makers from 65 countries. The three-day event attracts thousands of companies from around the world and helps build strategic partnerships. BIO covers the wide spectrum of life science innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries represented at the BIO International Convention.

 

Upcoming Conferences: March-April 2013

North America is home to some incredible conferences and conventions surrounding cancer research, therapy development and biotech investments. With the strength of the American biotech and life sciences industries, several of these lineage conferences have been around for decades. Many CEOs, scientists and clinical experts speak at the various events and chair panels to create discussions on various topics that are currently of large importance in medicine. Each quarter, we attend or keep our eye on at least a few of these events. For March and April, these are 4 of the upcoming conferences that we are interested in:


Real Time Web Analytics